Literature DB >> 33717128

The Immunopathology of Giant Cell Arteritis Across Disease Spectra.

Michelle L Robinette1, Deepak A Rao1, Paul A Monach1,2.   

Abstract

Giant cell arteritis (GCA) is a granulomatous systemic vasculitis of large- and medium-sized arteries that affects the elderly. In recent years, advances in diagnostic imaging have revealed a greater degree of large vessel involvement than previously recognized, distinguishing classical cranial- from large vessel (LV)- GCA. GCA often co-occurs with the poorly understood inflammatory arthritis/bursitis condition polymyalgia rheumatica (PMR) and has overlapping features with other non-infectious granulomatous vasculitides that affect the aorta, namely Takayasu Arteritis (TAK) and the more recently described clinically isolated aortitis (CIA). Here, we review the literature focused on the immunopathology of GCA on the background of the three settings in which comparisons are informative: LV and cranial variants of GCA; PMR and GCA; the three granulomatous vasculitides (GCA, TAK, and CIA). We discuss overlapping and unique features between these conditions across clinical presentation, epidemiology, imaging, and conventional histology. We propose a model of GCA where abnormally activated circulating cells, especially monocytes and CD4+ T cells, enter arteries after an unknown stimulus and cooperate to destroy it and review the evidence for how this mechanistically occurs in active disease and improves with treatment.
Copyright © 2021 Robinette, Rao and Monach.

Entities:  

Keywords:  CIA; GCA; LVV; PMR; Takayasu; giant cell arteritis; temporal arteritis; vasculitis

Year:  2021        PMID: 33717128      PMCID: PMC7946968          DOI: 10.3389/fimmu.2021.623716

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  175 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Clinically isolated aortitis: pitfalls, progress, and possibilities.

Authors:  Ilkay Cinar; He Wang; James R Stone
Journal:  Cardiovasc Pathol       Date:  2017-04-23       Impact factor: 2.185

3.  NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.

Authors:  Christian Dejaco; Christina Duftner; Juman Al-Massad; Annette D Wagner; Joon-Keun Park; Johannes Fessler; Ariane Aigelsreiter; Franz Hafner; Sandra Vega; William Sterlacci; Beatrix Grubeck-Loebenstein; Alexander Tzankov; Thomas Ness; Luigi Boiardi; Carlo Salvarani; Michael Schirmer
Journal:  Ann Rheum Dis       Date:  2013-02-15       Impact factor: 19.103

4.  Disease pattern in cranial and large-vessel giant cell arteritis.

Authors:  A Brack; V Martinez-Taboada; A Stanson; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1999-02

5.  Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis.

Authors:  V Martinez-Taboada; N N Hunder; G G Hunder; C M Weyand; J J Goronzy
Journal:  J Mol Med (Berl)       Date:  1996-11       Impact factor: 4.599

6.  Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica.

Authors:  Diana Prieto-Peña; Isabel Martínez-Rodríguez; Javier Loricera; Ignacio Banzo; Mónica Calderón-Goercke; Vanesa Calvo-Río; Carmen González-Vela; Alfonso Corrales; Santos Castañeda; Ricardo Blanco; José L Hernández; Miguel Á González-Gay
Journal:  Semin Arthritis Rheum       Date:  2018-05-18       Impact factor: 5.532

7.  Gelatinase expression and proteolytic activity in giant-cell arteritis.

Authors:  Marta Segarra; Ana García-Martínez; Montse Sánchez; José Hernández-Rodríguez; Ester Lozano; Josep M Grau; Maria C Cid
Journal:  Ann Rheum Dis       Date:  2007-05-14       Impact factor: 19.103

8.  Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis.

Authors:  Y Seko; S Minota; A Kawasaki; Y Shinkai; K Maeda; H Yagita; K Okumura; O Sato; A Takagi; Y Tada
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations.

Authors:  Christina Duftner; Christian Dejaco; Alexandre Sepriano; Louise Falzon; Wolfgang Andreas Schmidt; Sofia Ramiro
Journal:  RMD Open       Date:  2018-02-02

Review 10.  Racial Disparities in Rheumatology Through the Lens of Critical Race Theory.

Authors:  Jessica N Williams; Chandra L Ford; Michelle Morse; Candace H Feldman
Journal:  Rheum Dis Clin North Am       Date:  2020-11       Impact factor: 2.032

View more
  7 in total

Review 1.  [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

Authors:  Sabrina Arnold; Sebastian Klapa; Konstanze Holl-Ulrich; Antje Müller; Anja Kerstein-Stähle; Peter Lamprecht
Journal:  Z Rheumatol       Date:  2022-08-12       Impact factor: 1.530

Review 2.  Findings on the Relationship Between Intestinal Microbiome and Vasculitis.

Authors:  Boyuan Sun; Xin He; Wen Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

Review 3.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 4.  Looking ahead: giant-cell arteritis in 10 years time.

Authors:  Milena Bond; Alessandro Tomelleri; Frank Buttgereit; Eric L Matteson; Christian Dejaco
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-24       Impact factor: 3.625

5.  Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.

Authors:  Luka Bolha; Alojzija Hočevar; Alen Suljič; Vesna Jurčić
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

6.  Giant Cell Arteritis Mimicking Polymyalgia Rheumatica: A Challenging Diagnosis.

Authors:  Ryuichi Ohta; Tatsuhiko Okayasu; Noritaka Katagiri; Takafumi Yamane; Minami Obata; Chiaki Sano
Journal:  Cureus       Date:  2022-07-31

7.  Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.

Authors:  Marc Corbera-Bellalta; Roser Alba-Rovira; Sujatha Muralidharan; Georgina Espígol-Frigolé; Roberto Ríos-Garcés; Javier Marco-Hernández; Amanda Denuc; Farah Kamberovic; Patricia Pérez-Galán; Alexandra Joseph; Annalisa D'Andrea; Kent Bondensgaard; Maria C Cid; John F Paolini
Journal:  Ann Rheum Dis       Date:  2022-01-19       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.